Search research articles
Contact Us
Filters
Showing results (31-40 of 113) with videos related to
Page
of 12
Sort By:
The Journal of Clinical Investigation
|
July 1, 1978
A specific inhibitor of complement (C5)-derived chemotactic activity in serum from patients with systemic lupus erythematosus
H D Perez, M Lipton, I M Goldstein
The Journal of Biological Chemistry
|
December 25, 1983
A novel dioxygenation product of arachidonic acid possesses potent chemotactic activity for human polymorphonuclear leukocytes
S Shak, H D Perez, I M Goldstein
The Journal of Experimental Medicine
|
August 1, 1977
Influence of local anesthetics upon human polymorphonuclear leukocyte function in vitro. Reduction of lysosomal enzyme release and superoxide anion production
I M Goldstein, S Lind, S Hoffstein, et al.
The Journal of Laboratory and Clinical Medicine
|
January 1, 1984
Selective inhibition by phenytoin of chemotactic factor - stimulated neutrophil functions
R O Webster, I M Goldstein, M R Flick
Inflammation
|
September 1, 1980
Generation of a chemotactic lipid from a arachidonic acid by exposure to a superoxide-generating system
H D Perez, B B Weksler, I M Goldstein
Arthritis and Rheumatism
|
December 1, 1979
Infection in patients with systemic lupus erythematosus. Association with a serum inhibitor of complement-derived chemotactic activity
H D Perez, R I Andron, I M Goldstein
Transactions of the Association of American Physicians
|
January 1, 1989
Molecular basis for a polymorphism involving Fc receptor II on human monocytes
M R Clark, S B Clarkson, I M Goldstein
The American Journal of the Medical Sciences
|
September 1, 1981
Septic arthritis of the sternoclavicular joint due to gram-positive microorganisms
R S Friedman, H D Perez, I M Goldstein
Annals of Internal Medicine
|
April 1, 1976
Letter: Hypercalcemia: a possible cause for elevated serum lysozyme levels
I M Goldstein, J K Horn, H B Kaplan
The Journal of Clinical Investigation
|
December 1, 1986
Attachment of human C5a des Arg to its cochemotaxin is required for maximum expression of chemotactic activity
H D Perez, D E Chenoweth, I M Goldstein
Page
of 12
Search research articles
Search
Showing results (31-40 of 113) with videos related to
Sort By:
Page
of 12
The Journal of Clinical Investigation
|
July 1, 1978
A specific inhibitor of complement (C5)-derived chemotactic activity in serum from patients with systemic lupus erythematosus
H D Perez, M Lipton, I M Goldstein
The Journal of Biological Chemistry
|
December 25, 1983
A novel dioxygenation product of arachidonic acid possesses potent chemotactic activity for human polymorphonuclear leukocytes
S Shak, H D Perez, I M Goldstein
The Journal of Experimental Medicine
|
August 1, 1977
Influence of local anesthetics upon human polymorphonuclear leukocyte function in vitro. Reduction of lysosomal enzyme release and superoxide anion production
I M Goldstein, S Lind, S Hoffstein, et al.
The Journal of Laboratory and Clinical Medicine
|
January 1, 1984
Selective inhibition by phenytoin of chemotactic factor - stimulated neutrophil functions
R O Webster, I M Goldstein, M R Flick
Inflammation
|
September 1, 1980
Generation of a chemotactic lipid from a arachidonic acid by exposure to a superoxide-generating system
H D Perez, B B Weksler, I M Goldstein
Arthritis and Rheumatism
|
December 1, 1979
Infection in patients with systemic lupus erythematosus. Association with a serum inhibitor of complement-derived chemotactic activity
H D Perez, R I Andron, I M Goldstein
Transactions of the Association of American Physicians
|
January 1, 1989
Molecular basis for a polymorphism involving Fc receptor II on human monocytes
M R Clark, S B Clarkson, I M Goldstein
The American Journal of the Medical Sciences
|
September 1, 1981
Septic arthritis of the sternoclavicular joint due to gram-positive microorganisms
R S Friedman, H D Perez, I M Goldstein
Annals of Internal Medicine
|
April 1, 1976
Letter: Hypercalcemia: a possible cause for elevated serum lysozyme levels
I M Goldstein, J K Horn, H B Kaplan
The Journal of Clinical Investigation
|
December 1, 1986
Attachment of human C5a des Arg to its cochemotaxin is required for maximum expression of chemotactic activity
H D Perez, D E Chenoweth, I M Goldstein
Page
of 12